iSBTc 21st Annual Scientific Meeting

International Society for Biological Therapy of Cancer (iSBTc)
Last Modified: January 29, 2006

Conference Dates: October 26-29, 2006
Conference Location: Century City, Los Angeles, California

Sponsoring Group: International Society for Biological Therapy of Cancer (iSBTc)

Conference Web Page URL: www.isbtc.org

Topics Covered: Dendritic Cells/Vaccines, Adoptive Therapy, Cytokines, Immune Monitoring, Immunoregulation/Costimulation, Antibodies, TLR/Innate Immunity, New Agents in Targeted Therapies, Angiogenesis, Biologic Effects of Targeted Therapeutics, Primer on Immunology and Biological Therapy

Conference Objectives: Offer an international forum where immunologic and biologic approaches to cancer treatment are presented, discussed and critically evaluated.

Who Should Attend: Basic and clinical investigators from academic, regulatory and biopharmaceutical venues. Clinicians, reserachers, students, post-doctoral fellows, allied health professionals

Conference Agenda: Thurs, Oct. 26: Primer on Tumor Immunology and Biological Therapy Workshop on Biologic Effects of Targeted Therapeutics Fri, Oct. 27 - Sun, Oct. 29: Keynote Addresses, State of the Art Lectures, Abstract Presentations, Poster Presentations, Poster Discussion Sessions, Networking Receptions

Registration Information: For registration and conference information, visit www.isbtc.org

Conference Fees: Variable

Continuing Education: No

Miscellany: Abstract Deadline: July 17, 2006

Related News

Intra-arterial yttrium-90 microspheres may prolong survival and improve quality of life

Mar 18, 2010

Intra-arterial yttrium-90 microspheres may prolong survival and improve quality of life


Radiofrequency ablation targets tumor, spares healthy liver tissue, can add several years to life

Mar 18, 2010

Radiofrequency ablation targets tumor, spares healthy liver tissue, can add several years to life


Image-guided 'nanoembolization' can deliver cancer-killing agent directly to pancreatic tumor

Mar 17, 2010

Image-guided 'nanoembolization' can deliver cancer-killing agent directly to pancreatic tumor


Frequently Asked Questions